Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (481-490 of 514) with videos related to

Pageof 52
Sort By:
Targeted Oncology|December 27, 2015
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based TherapyEric Van Cutsem, Florence Joulain, Paulo M Hoff, et al.
Physical Review Letters|April 16, 2021
Observation of the Exotic Isotope ^{13}F Located Four Neutrons beyond the Proton Drip LineR J Charity, T B Webb, J M Elson, et al.
Arquivos Brasileiros De Cardiologia|October 7, 2020
Cancer and Cardiovascular Diseases during the COVID-19 PandemicLucas Tokio Kawahara, Isabela Bispo Santos da Silva Costa, Cecília Chie Sakaguchi Barros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III TrialJ Randolph Hecht, Yung-Jue Bang, Shukui K Qin, et al.
JAMA Network Open|October 19, 2020
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT TrialBenoist Chibaudel, Julie Henriques, Manel Rakez, et al.
Physical Review Letters|January 12, 2024
Direct Mass Measurements to Inform the Behavior of ^{128m}Sb in Nucleosynthetic EnvironmentsD E M Hoff, K Kolos, G W Misch, et al.
Physical Review Letters|November 13, 2023
Strong Evidence for ^{9}N and the Limits of Existence of Atomic NucleiR J Charity, J Wylie, S M Wang, et al.
Journal of the American Academy of Dermatology|July 22, 2024
From sunbeds to sunscreen: A curriculum empowering oregon adolescents to take charge of their skin healthVictoria E Orfaly, Gina N Bash, Erin Risotto-Urbanowicz, et al.
Intensive Care Medicine|August 10, 2020
Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort studyFernando G Zampieri, Thiago G Romano, Jorge I F Salluh, et al.
Plos One|November 17, 2011
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patientsJoão L Miraglia, Edson Abdala, Paulo M Hoff, et al.
Pageof 52

Showing results (481-490 of 514) with videos related to

Sort By:
Pageof 52
Targeted Oncology|December 27, 2015
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based TherapyEric Van Cutsem, Florence Joulain, Paulo M Hoff, et al.
Physical Review Letters|April 16, 2021
Observation of the Exotic Isotope ^{13}F Located Four Neutrons beyond the Proton Drip LineR J Charity, T B Webb, J M Elson, et al.
Arquivos Brasileiros De Cardiologia|October 7, 2020
Cancer and Cardiovascular Diseases during the COVID-19 PandemicLucas Tokio Kawahara, Isabela Bispo Santos da Silva Costa, Cecília Chie Sakaguchi Barros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III TrialJ Randolph Hecht, Yung-Jue Bang, Shukui K Qin, et al.
JAMA Network Open|October 19, 2020
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT TrialBenoist Chibaudel, Julie Henriques, Manel Rakez, et al.
Physical Review Letters|January 12, 2024
Direct Mass Measurements to Inform the Behavior of ^{128m}Sb in Nucleosynthetic EnvironmentsD E M Hoff, K Kolos, G W Misch, et al.
Physical Review Letters|November 13, 2023
Strong Evidence for ^{9}N and the Limits of Existence of Atomic NucleiR J Charity, J Wylie, S M Wang, et al.
Journal of the American Academy of Dermatology|July 22, 2024
From sunbeds to sunscreen: A curriculum empowering oregon adolescents to take charge of their skin healthVictoria E Orfaly, Gina N Bash, Erin Risotto-Urbanowicz, et al.
Intensive Care Medicine|August 10, 2020
Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort studyFernando G Zampieri, Thiago G Romano, Jorge I F Salluh, et al.
Plos One|November 17, 2011
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patientsJoão L Miraglia, Edson Abdala, Paulo M Hoff, et al.
Pageof 52